Sustainability

Enable people to fulfil the dream of having a healthy baby

The Vitrolife Group’s management and Board of Directors have resolved that sustainability must be integrated into everything we do. Based on a thorough analysis of the value chain, four long-term sustainability themes have been identified on which we will focus our efforts.

The themes enable the effective integration of sustainability into the core business by setting long-term ambitions and direct measures in line with our material sustainability issues. In 2023, we have set long term ambitions and identified appropriate KPIs to monitor progress for each theme.

Ensuring sustainability in everything we do
The Vitrolife Group’s management and Board of Directors have resolved that sustainability must be integrated into everything we do.

Within the context of our sustainability strategy, we have identified key performance indicators to follow and track progress on our sustainability ambitions.

Complementing the primary performance indicator for each theme, we employ additional relevant indicators to effectively monitor and track our progress. The tables on the following pages provide a concise summary of the indicators.

Vitrolife Group Annual and Sustainability Report for 2025
We are pleased to announce the release of Vitrolife Group’s Annual Report for 2025. Despite a volatile market, we delivered a resilient performance, continued to gain market share in key regions, and maintained our strategic focus on growth, innovation, and operational excellence.

Purpose-driven growth

We aim to develop world-class products that improve the treatment quality and outcomes for the clinics and the final patient, including through improved access to products, services, and information.

This can only be achieved by maintaining a sharp focus on innovating for and with our customers and never losing sight of our final purpose and goal: to unlock the full potential of reproductive science and technology to reduce the barriers to building a family, and thus fulfilling the dream of having a healthy baby.

Ethical profitability

As a company with a strong tradition of profitable growth, we acknowledge that operating profitably cannot be sustainable without ensuring ethical decision-making and responsible business conduct throughout the value chain.

To this end, we aim to ensure that all of our partners, suppliers and distributors are in line with the standards we apply to ourselves in terms of ethics, quality and sustainability.

Planet accountability

We are committed to contributing to accelerating the transition to a low-carbon economy and helping to prevent the worst impacts of climate change by minimizing our greenhouse gas emissions and reducing our resource use.

We are committed to doing our part and ensuring our operations are in line with the expectations set for companies by the Paris agreement. We have validated 2030 near-term Science Based Targets initiative (SBTi) targets, demonstrating our commitment to ambitious, science-based climate action.

Inclusive engagement

We strive to create an inclusive culture, where everyone has equal rights and opportunities regardless of aspects such as gender, nationality, ethnicity, religion, age, sexual orientation, or other status.

A fair distribution of opportunities between gender, as well as zero tolerance for discrimination, are important prerequisites for the Vitrolife Group globally. To make sure we don’t fall behind this goal, we have created an internal diversity and inclusion (D&I) index that will help us control and keep track of our progress in the years to come. Together with inclusion, ensuring that we foster an organisation with high engagement and where everyone is empowered to be at their best is a top priority.

External recognitions and partnerships

ESG focus

Vitrolife AB is a certified “Nasdaq ESG Transparency Partner”. A certification that is awarded to Nasdaq-listed companies that actively work on sustainability issues and related reporting. This is confirmation of the Vitrolife Group´s desire to be transparent vis-à-vis the market in respect of the Group’s sustainability status with regard to current and future investors, employees, customers and other stakeholders.

Signatory to the UN Women’s Empowerment Principles

This program, an initiative of UN Women and the United Nations Global Compact, defines seven principles that foster the empowerment of women in the workplace, the marketplace, and the community.

Principle 1: Establish high-level corporate leadership for gender equality
Principle 2: Treat all women and men fairly at work - respect and support human rights and non-discrimination
Principle 3: Ensure the health, safety and well-being of all women and men workers
Principle 4: Promote education, training and professional development for women
Principle 5: Implement enterprise development, supply chain and marketing practices that empower women
Principle 6: Promote equality through community initiatives and advocacy
Principle 7: Measure and publicly report on progress to achieve gender equality

United Nations Global Compact

As part of our commitment to sustainable and responsible business practices, The Vitrolife Group has embedded the Ten Principles of the United Nations Global Compact into strategies and operations, and committed to respecting human and labour rights, safeguarding the environment, and working against corruption in all its forms.

MedTech Europe

MedTech Europe is the European trade association for the medical technology industry including diagnostics, medical devices and digital health. Its members are national, European and multinational companies as well as a network of national medical technology associations who research, develop, manufacture, distribute and supply health-related technologies, services and solutions.

Learn more This is link to Learn more

Sedex

The Vitrolife Group is a member of Sedex, a world-leading organization in supply chain sustainability. This partnership underscores our commitment to upholding high ethical, environmental, and human rights standards throughout our supply chain. Sedex’s technology and data tools help enhance supply chain mapping, risk assessments, and drive positive impacts, all of which are crucial to achieving our sustainability goals.

Reporting and Policies

Vitrolife Group's Code of Conduct

Vitrolife Group requires all employees and distributors to sign and comply with Vitrolife Group's Code of Conduct (Principles for Responsible Business Conduct). In 2020 the Code of Conduct was reinforced with a separate policy that gives guidance to healthcare professionals and business partners on cooperation with health care and medical care actors and care staff. All distributors have signed Vitrolife Group's Code of Conduct. When selecting and qualifying suppliers with regard to the purchase of materials for production, one of the selection criteria is that suppliers comply with and work in accordance with Vitrolife Group's Code of Conduct.

Vitrolife Group's Code of Conduct

Environmental policy

At Vitrolife Group, we are committed to protecting the environment and integrating sustainability into every part of our business. As a global provider of medical devices and genetic testing solutions for assisted reproduction, we work proactively to reduce our environmental footprint across our operations, products, and value chain.

The Vitrolife Group head office, including the production facility in Gothenburg, is certified in accordance with the environmental management system standard ISO14001.

Our Key Commitments
• Climate action: Monitor and reduce greenhouse gas emissions in line with science based targets.
• Responsible resource use: Improve energy, water, and material efficiency and integrate circular economy principles where feasible.
• Waste reduction: Minimize waste and ensure safe, compliant handling of all waste streams.
• Pollution prevention: Strengthen controls on chemicals and hazardous materials, and work to replace substances of concern with safer alternatives.
• Continuous improvement: Set, monitor, and review environmental objectives across our global operations.

Whistleblower function

Vitrolife Group strives to achieve a high level of business ethics and transparency. Our employees are an important source of insight for revealing possible serious irregularities that must be addressed. The whistleblowing team consists of senior position holders within compliance related functions like Legal, Human Resources and Internal Control and Risk Management.

Link to external partner for whistleblower function

Modern Slavery Statement

Pursuant to Section 54(1) of the UK Modern Slavery Act 2015 and Section 16 of the Australian Modern Slavery Act 2018, we hereby publish our Modern Slavery and Human Trafficking Statement. This statement, approved by our Board of Directors, outlines Vitrolife Group's commitment and efforts to prevent modern slavery and human trafficking in our operations and supply chains.

Modern Slavery Statement

Disclaimer

The use by Vitrolife AB of any MSCI ESG research llc or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Vitrolife AB by MSCI. MSCI services and data are the property of MSCI or its information providers, and are provided ‘as-is’ and without warranty. MSCI names and logos are trademarks or service marks of MSCI.